U.S. market Closed. Opens in 4 hours 47 minutes

AZN | AstraZeneca PLC Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for AZN we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is exceptionally good and Health is very weak.

Valuation (59%)

Company Industry
P/E Ratio (TTM) 31.47 76.61
PEG Ratio (TTM) 43.54 2.79
P/S Ratio (TTM) 3.98 7.31
P/B Ratio (TTM) 5.02 21.34
P/FCF Ratio (TTM) 30.18 -69.81
Price to 5YR AVG Earnings Ratio 34.97 49.13
Price to 5YR AVG FCF Ratio 50.68 76.25

Profitability (40%)

Company Industry
ROA (TTM) 6.19% 6.68%
ROE (TTM) 16.57% 34.95%
Net Profit Margin (TTM) 12.68% 13.64%
ROIC 5YR AVG 8.79% 20.65%

Growth (87%)

4QTR AVG 3YR AVG 5YR AVG
EPS 6.18% 20.45% 520.38%
Revenue 4.24% 20.04% 16.39%
Net Income 14.86% 1.62% 584.34%
Cash Flow 3.66% 33.10% 33.85%

Health (39%)

Company Industry
Current Ratio (TTM) 0.93 1.14
Quick Ratio (TTM) 0.71 0.89
D/E Ratio (TTM) 0.74 2.80
Interest Coverage (TTM) 5.35 13.95
Piotroski F-Score 6 6
Altman Z-Score 2.74 4.18
LTL to 5YR AVG FCF 5.73 4.08
Shares Outstanding Growth 5YR AVG 13.91% 0.69%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙